US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
445 deals · US$333bndisclosed · Healthcare · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Apr 2026 | Exclusive global rights to TAK-063 (balipodect) | Takeda Pharmaceutical Co. | Axsome Therapeutics | Asset sale | Completed | – | Pharma+1 | Sidley Austin (buy-side) |
| Apr 2026 | Forian | – | Max Wygod | Acquisition | Announced | 68.0 | Healthcare Software+1 | Houlihan Lokey (sell-side)Potter Anderson & Corroon (sell-side)Miles & Stockbridge (sell-side)Duane Morris (sell-side)A&O Shearman (buy-side)Abrams & Bayliss (buy-side)Venable (buy-side) |
| Apr 2026 | EpiVax | – | SV Health Investors | Acquisition | Announced | – | Pharma Services+2 | Morgan Lewis (buy-side) |
| Apr 2026 | View Point Medical | – | Merit Medical Systems | Acquisition | Completed | 140.0 | Medtech+1 | Piper Sandler (buy-side)Baker McKenzie (buy-side) |
| Apr 2026 | HLSG Intermediate | – | – | Acquisition | Announced | – | Healthcare Services+1 | Latham & Watkins (buy-side) |
| Apr 2026 | Cumberland U.S. branded businesses | Cumberland Pharmaceuticals | Apotex | Asset sale | Announced | – | Pharma | Kirkland & Ellis (buy-side) |
| Apr 2026 | Thermo Fisher Scientific's microbiology division | Thermo Fisher Scientific | Astorg | Asset sale | Announced | 1,075.0 | Diagnostics+1 | Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side) |
| Apr 2026 | IntusCare | – | Blue Star Innovation Partners | Acquisition | Announced | – | Healthcare Software+1 | Kirkland & Ellis (buy-side) |
| Apr 2026 | Faithful Companion | – | Freedom 3 Capital | Stake | Completed | – | Healthcare Services | William Blair |
| Apr 2026 | McKesson Medical-Surgical Solutions (MMS) business | McKesson | Funds managed by affiliates of Apollo | Stake | Pending | 1,250.0 | Distribution+1 | Davis Polk (sell-side)Latham & Watkins (buy-side) |
| Apr 2026 | Midwest Products & Engineering | – | Graham Partners | Acquisition | Completed | – | Medtech+1 | Kirkland & Ellis (sell-side)Baird (sell-side)Dechert (buy-side) |
| Apr 2026 | Surgistar | – | Halma | Acquisition | Completed | – | Medtech | Baird (sell-side) |
| Apr 2026 | Modeyso commercial sales royalties | Former Oncoceutics Inc. securityholders | HealthCare Royalty | Asset sale | Announced | – | Specialty finance and leasing+3 | Latham & Watkins (sell-side) |
| Apr 2026 | Jopari Solutions | – | Office Ally | Acquisition | Completed | – | Healthcare Software+1 | TripleTreeKirkland & Ellis (buy-side) |
| Apr 2026 | TriNetX | – | Regeneron Pharmaceuticals | Stake | Completed | – | Healthcare Software+2 | William Blair |
| Apr 2026 | Dane Street | – | – | Stake | Announced | – | Healthcare Services+1 | Latham & Watkins (sell-side) |
| Apr 2026 | Staritas | ECRI | – | Demerger | Announced | – | Healthcare Software+1 | Kirkland & Ellis |
| Apr 2026 | Peachy | – | Stride Conumer Partners | Stake | Announced | – | Medical Aesthetics+2 | Raymond JamesLatham & Watkins (buy-side) |
| Apr 2026 | Amplitude Vascular Systems | – | Stryker | Acquisition | Completed | 835.0 | Medtech+1 | Perella Weinberg Partners (sell-side) |
| Apr 2026 | Modersys (fka SmartFactory Rx) | Applied Materials | TELEO Capital | Asset sale | Completed | – | Industrial Software+1 | Lazard |
| Apr 2026 | Celerion | H.I.G. Capital affiliate | THL Partners | Acquisition | Announced | – | Pharma Services+2 | LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side) |
| Mar 2026 | Apellis Pharmaceuticals | – | Biogen | Acquisition | Announced | 5,600.0 | Biotech+2 | Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)WilmerHale (sell-side)Cravath, Swaine & Moore (buy-side) |
| Mar 2026 | Centessa Pharmaceuticals | – | Eli Lilly and Company | Scheme | Pending | 6,300.0 | Biotech+1 | Centerview Partners (sell-side)Jefferies (sell-side)Goodwin (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side) |
| Mar 2026 | Vital Data Technology | – | MedReview | Acquisition | Completed | – | Healthcare Software+2 | Bailey & Company (sell-side)Sheppard, Mullin, Richter & Hampton (sell-side)Synergy Advisors (buy-side)Goodwin (buy-side) |
| Mar 2026 | Majestic Medical Solutions | – | Radon Medical Imaging | Acquisition | Completed | – | Healthcare Services | DLA Piper (buy-side) |
| Mar 2026 | Kezar Life Sciences | – | Aurinia Pharmaceuticals | Acquisition | Announced | 51.5 | Biotech+1 | TD Securities (sell-side)Cooley (sell-side) |
| Mar 2026 | AnaptysBio outstanding common stock | – | AnaptysBio | Buy-back | Announced | 100.0 | Biotech+1 | Piper Sandler (buy-side) |
| Mar 2026 | HealthTech Solutions | – | Health Management Associates | Acquisition | Announced | – | Healthcare Software+1 | Synergy Advisors (sell-side) |
| Mar 2026 | Eos SENOLYTIX | – | Pulmatrix | Merger | Announced | – | Biotech+1 | Palladium Capital Group (buy-side)Evolution Venture Partners (sell-side)Wilk Auslander (sell-side)Gemini Valuation Services (buy-side)Haynes Boone (buy-side) |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Announced | 1,675.0 | Biotech+1 | Paul, WeissGoodwin (sell-side)Centerview Partners (buy-side) |
| Mar 2026 | Terns Pharmaceuticals | – | Merck & Co. | Acquisition | Announced | 6,700.0 | Biotech+2 | Centerview Partners (sell-side)Freshfields (sell-side)Jefferies (sell-side)Covington & Burling (buy-side)Gibson Dunn (buy-side) |
| Mar 2026 | Syntegon | CVC Capital Partners | Apollo | Stake | Announced | – | Manufacturing+2 | Willkie Farr & Gallagher (sell-side)Sidley Austin (buy-side) |
| Mar 2026 | EyeSouth Partners’ retina business | EyeSouth Partners | Cencora | Asset sale | Announced | 1,100.0 | Healthcare Services+1 | Jefferies (sell-side)Kirkland & Ellis (sell-side)BofA Securities (buy-side)Citi (buy-side)Sidley Austin (buy-side) |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Announced | 2,000.0 | Biotech+2 | Goodwin (sell-side)Centerview Partners (sell-side) |
| Mar 2026 | DME Express | WayPoint Capital Partners | Palladium Equity Partners | Acquisition | Completed | – | Healthcare Services+1 | KeyBanc Capital Markets (sell-side)Holland & Knight (sell-side)Katten Muchin Rosenman (sell-side)Edgemont Partners (buy-side)Morrison & Foerster (buy-side) |
| Mar 2026 | AZSTARYS business | Corium Therapeutics Holdings | Collegium Pharmaceutical | Asset sale | Pending | 650.0 | Pharma | Centerview Partners (sell-side)Sullivan & Cromwell (sell-side)Leerink Partners (buy-side)Goodwin (buy-side) |
| Mar 2026 | Owen Mumford Holdings | – | Embecta Corp. | Acquisition | Pending | 132.2 | Medtech+1 | Forvis Mazars (South Africa) (sell-side)Mills & Reeve (sell-side)J.P. Morgan (buy-side)A&O Shearman (buy-side) |
| Mar 2026 | Golden Rule Hospice | – | James River Home Health | Acquisition | Completed | – | Healthcare Services | The Braff Group (sell-side) |
| Mar 2026 | Stratis Group | – | Nexus Health | Acquisition | Announced | – | Accounting, legal and consulting+1 | Clearsight Advisors (sell-side)Pillsbury Winthrop Shaw Pittman (sell-side) |
| Mar 2026 | The Physical Therapy and Rehabilitation Center | – | SportsMed Physical Therapy | Acquisition | Announced | – | Healthcare Services | Holland & Knight (buy-side) |
| Mar 2026 | MedCare Express | – | AMKY Health CT | Acquisition | Announced | – | Healthcare Services+1 | Osage Advisors (sell-side) |
| Mar 2026 | Asian Egg Bank | – | CSG.BIO | Acquisition | Completed | – | Healthcare Services | Provident Healthcare Partners (sell-side)Nixon Peabody (sell-side)Venable (buy-side) |
| Mar 2026 | A Caring Experience Nursing Services | – | HouseWorks Holdings | Acquisition | Announced | – | Healthcare Services+1 | Provident Healthcare Partners (sell-side)Nixon Peabody (sell-side)Goodwin (buy-side)Reed Smith (buy-side) |
| Mar 2026 | Selectis Health | – | Black Pearl Equities | Acquisition | Announced | – | Aged Care+1 | Pearson Butler (sell-side)Houlihan Valuation Advisors (sell-side)Olshan Frome Wolosky (buy-side)Laurel Hill Advisory Group (buy-side) |
| Mar 2026 | Mytonomy | – | Elsevier | Acquisition | Completed | – | Healthcare Software | Perella Weinberg Partners (sell-side)Cravath, Swaine & Moore (buy-side) |
| Mar 2026 | Biocare Medical | – | Agilent Technologies | Acquisition | Announced | 950.0 | Diagnostics+1 | Sullivan & Cromwell (buy-side) |
| Mar 2026 | Covenant Home Health | – | Residential Home Health | Acquisition | Completed | – | Healthcare Services | |
| Mar 2026 | Talkspace | – | Universal Health Services | Acquisition | Announced | 835.0 | Behavioral Health | Wells Fargo Securities (sell-side)Cravath, Swaine & Moore (sell-side)J.P. Morgan (buy-side)McDermott Will & Schulte (buy-side)Stevens & Lee (buy-side) |
| Mar 2026 | Roger Williams Medical Center and Our Lady of Fatima Hospital | Prospect Medical Holdings | Centurion Foundation | Acquisition | Completed | – | Healthcare Services | Hall, Render, Killian, Heath & Lyman (buy-side) |
| Mar 2026 | Lisata Therapeutics | – | Kuva Labs | Acquisition | Pending | – | Biotech+2 | Mintz (sell-side)H.C. Wainwright & Co. (sell-side)Goodwin (buy-side)Campaign Management (buy-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built